Episode 11

How Lab Contracts are Constraining Practice Valuation

Feb. 23rd, 2021

This week on the Consolidate That! Ryan and Ivan talk with Mark DeCourcy, CEO at Ellie Diagnostics, about diagnostics’ role in the patient journey and the significant impact on EBITDA for veterinary consolidators.

Topics discussed:

  • Percentage of revenue from diagnostics;
  • Optimization of the clinic’s workflow by transitioning to a laboratory partner;
  • How eliminating contracts increases the practices’ value;
  • Impact of preventive diagnostic tests on the total revenue for the clinic;
  • Ellie Diagnostics’ innovative business model;


mark decourcy
Mark DeCourcy
CEO at Ellie Diagnostics
ivan zak
Dr. Ivan Zak
DVM, MBA, CEO at Galaxy Vets
ryan leech
Ryan Leech
Head of Business Development at Galaxy Vets